Free Trial

Timber Creek Capital Management LLC Buys New Shares in Centene Corporation (NYSE:CNC)

Centene logo with Medical background

Timber Creek Capital Management LLC purchased a new stake in shares of Centene Corporation (NYSE:CNC - Free Report) in the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 55,675 shares of the company's stock, valued at approximately $3,380,000.

Several other institutional investors have also recently made changes to their positions in the stock. MassMutual Private Wealth & Trust FSB lifted its stake in shares of Centene by 8.8% during the 1st quarter. MassMutual Private Wealth & Trust FSB now owns 2,092 shares of the company's stock worth $127,000 after buying an additional 169 shares during the last quarter. Private Trust Co. NA grew its position in shares of Centene by 23.7% in the fourth quarter. Private Trust Co. NA now owns 956 shares of the company's stock valued at $58,000 after purchasing an additional 183 shares during the last quarter. Intellectus Partners LLC lifted its holdings in Centene by 2.8% during the 4th quarter. Intellectus Partners LLC now owns 7,224 shares of the company's stock worth $438,000 after purchasing an additional 200 shares during the last quarter. MV Capital Management Inc. increased its position in Centene by 0.6% during the 4th quarter. MV Capital Management Inc. now owns 31,889 shares of the company's stock worth $1,932,000 after buying an additional 202 shares during the period. Finally, AlphaQuest LLC lifted its holdings in shares of Centene by 1.7% during the fourth quarter. AlphaQuest LLC now owns 16,142 shares of the company's stock worth $978,000 after buying an additional 263 shares in the last quarter. Institutional investors and hedge funds own 93.63% of the company's stock.

Wall Street Analyst Weigh In

Several analysts have weighed in on the stock. Barclays dropped their price objective on shares of Centene from $65.00 to $45.00 and set an "equal weight" rating for the company in a research note on Wednesday. Guggenheim reissued a "neutral" rating on shares of Centene in a research report on Tuesday, April 29th. UBS Group reiterated a "neutral" rating and set a $45.00 target price (down from $80.00) on shares of Centene in a research report on Wednesday. Morgan Stanley initiated coverage on shares of Centene in a research report on Monday, June 9th. They set an "overweight" rating and a $70.00 price objective for the company. Finally, Robert W. Baird decreased their target price on shares of Centene from $71.00 to $69.00 and set a "neutral" rating on the stock in a report on Tuesday, April 15th. Ten research analysts have rated the stock with a hold rating and eight have issued a buy rating to the company's stock. Based on data from MarketBeat, the company currently has an average rating of "Hold" and a consensus price target of $68.87.

Read Our Latest Analysis on CNC

Centene Trading Down 1.5%

Shares of CNC stock traded down $0.51 during trading hours on Friday, hitting $33.28. 33,741,422 shares of the company were exchanged, compared to its average volume of 5,446,665. The company has a debt-to-equity ratio of 0.65, a quick ratio of 1.11 and a current ratio of 1.11. Centene Corporation has a fifty-two week low of $33.30 and a fifty-two week high of $80.59. The company has a 50 day simple moving average of $56.42 and a two-hundred day simple moving average of $59.22. The firm has a market cap of $16.56 billion, a P/E ratio of 4.96, a P/E/G ratio of 0.45 and a beta of 0.44.

Centene (NYSE:CNC - Get Free Report) last posted its earnings results on Friday, April 25th. The company reported $2.90 earnings per share for the quarter, topping analysts' consensus estimates of $2.52 by $0.38. The company had revenue of $46.62 billion for the quarter, compared to analyst estimates of $43.16 billion. Centene had a net margin of 2.04% and a return on equity of 14.56%. The firm's revenue was up 15.4% compared to the same quarter last year. During the same quarter in the prior year, the business posted $2.26 EPS. Equities analysts anticipate that Centene Corporation will post 6.86 EPS for the current year.

About Centene

(Free Report)

Centene Corporation operates as a healthcare enterprise that provides programs and services to under-insured and uninsured families, commercial organizations, and military families in the United States. The company operates through Medicaid, Medicare, Commercial, and Other segments. The Medicaid segment offers health plan coverage, including medicaid expansion, aged, blind, disabled, children's health insurance program, foster care, medicare-medicaid plans, long-term services and support.

See Also

Institutional Ownership by Quarter for Centene (NYSE:CNC)

Should You Invest $1,000 in Centene Right Now?

Before you consider Centene, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Centene wasn't on the list.

While Centene currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

20 Stocks to Sell Now Cover

Today, we are inviting you to take a free peek at our proprietary, exclusive, and up-to-the-minute list of 20 stocks that Wall Street's top analysts hate.

Many of these appear to have good fundamentals and might seem like okay investments, but something is wrong. Analysts smell something seriously rotten about these companies. These are true "Strong Sell" stocks.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

3 Cheap Growth Stocks Set to Explode This Summer
The Next NVIDIA? Quantum Computing Stocks Set for Explosive Growth
5 Stocks to BUY NOW in July 2025

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines